August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug TRIJARDY XR Posted in: Uncategorized
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent expiration for Boehringer Ingelheim drug TRIJARD…
August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug GLYXAMBI Posted in: Uncategorized
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent expiration for Boehringer Ingelheim drug GLYX…
